Cortical Plasticity in Autism Spectrum Disorders

自闭症谱系障碍中的皮质可塑性

• 批准号: 9267535
• 负责人: Alvaro Pascual-Leone
• 金额: $ 43.77万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-15 至 2019-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9267535
• 关键词: 21 year old; 5 year old; Address; Adult; Affect; Age; Animal Model; Animals; Area; Asperger Syndrome; Attention; Autistic Disorder; Behavior; Behavioral; Biological Markers; Brain; Cerebral Palsy; Child; Childhood; Clinical; Clinical Trials; Cognitive; Complex; Data; Detection; Development; Diagnosis; Disease model; Early Diagnosis; Early Intervention; Etiology; Functional disorder; Future; Gender; Goals; Guidelines; Human; In Vitro; Incidence; Individual; Institutional Review Boards; Intellectual functioning disability; Knowledge; Lead; Life; Link; Longevity; Measures; Methodology; Methods; Modification; Molecular; Motor; Motor Cortex; Motor Evoked Potentials; Neurobiology; Neurosciences; Participant; Patients; Phenotype; Physiologic pulse; Physiological; Prevention; Protocols documentation; Publishing; Research; Risk Factors; Rodent; Secure; Specificity; Symptoms; Synaptic plasticity; Techniques; Testing; TimeLine; Training; Transcranial magnetic stimulation; Treatment Efficacy; Work; autism spectrum disorder; base; clinical Diagnosis; cognitive ability; cohort; developmental disease; effective therapy; endophenotype; in vivo; indexing; neuroimaging; neurophysiology; novel; potential biomarker; predictive of treatment response; public health relevance; repetitive transcranial magnetic stimulation; research study; response; safety and feasibility; social; trait; treatment response

DESCRIPTION (provided by applicant): The clinical, social and financial burden of Autism Spectrum Disorders (ASD) is staggering. They are the most prevalent of the developmental disorders and their incidence is rising. However, the ASD phenotype variability is large, and ASD symptoms can manifest over a range of ages and to different degrees. In part for these reasons, the ASD clinical diagnosis is challenging and often is not made until 3-5 years of age. Thus, there remains an unmet need for a valid and reliable endophenotype which would facilitate ASD diagnosis early in life, enable efficient study of ASD risk factors, and eventually serve as a useful biomarker to inform the development of effective therapies and assess treatment response in future clinical trials. The overarching goal of this proposal is to explore te utility of transcranial magnetic stimulation (TMS) measures of brain plasticity as a novel neurophysiologic endophenotype in high- and low-functioning adults and children with ASD. Our work to date demonstrates the potential utility of these measures in higher-functioning adults with ASD, and pilot data support the feasibility and safety of applying the same measures to children and lower functioning individuals in whom the value of such an endophenotype would be particularly high. We thus propose to apply single-pulse TMS to evaluate the modulation in corticospinal reactivity induced by a specific repetitive TMS protocol known as theta burst stimulation (TBS). The comparison of the motor responses induced by single-pulse TMS before and following TBS is a unique noninvasive measure of brain plasticity in humans, and we have found that it shows a reliable abnormality in high-functioning adult individuals with ASD. Our hypothesis is that the alteration of TBS-induced modulation of TMS responses is a common neuropathophysiologic trait that is reliably linked to the ASD phenotype, and that will not be limited to high functioning adults but be also valid in children and low-functioning individuals. W thus anticipate that data from the proposed studies will address an important need for a rapid, noninvasive, reliable and safe endophenotype available to patients with ASD across ages and level of function.

描述(由申请人提供)：自闭症谱系障碍(ASD)的临床、社会和经济负担令人震惊。它们是最常见的发育障碍，其发病率正在上升。然而，ASD的表型变异性很大，ASD症状可以在不同年龄和不同程度上表现出来。部分由于这些原因，ASD的临床诊断具有挑战性，通常要到3-5岁才能做出诊断。因此，对有效和可靠的ASD内表型的需求仍然没有得到满足，这种内表型将有助于ASD的早期诊断，使ASD危险因素能够有效地研究，并最终作为一个有用的生物标志物，在未来的临床试验中为有效治疗的发展和评估治疗反应提供信息。这项建议的首要目标是探索经颅磁刺激(TMS)测量大脑可塑性作为一种新的神经生理内表型在ASD高功能和低功能成人和儿童中的应用。到目前为止，我们的工作证明了这些措施在功能较高的自闭症成人中的潜在效用，试点数据支持将同样的措施应用于这种内表型价值特别高的儿童和功能较低的人的可行性和安全性。因此，我们建议应用单脉冲TMS来评估一种特定的重复性TMS方案所诱导的皮质脊髓反应性的调制，该方案被称为theta Burst刺激(TBS)。TBS前后单脉冲TMS诱发的运动反应的比较是一种独特的无创性测量人类大脑可塑性的方法，我们发现它在高功能成人ASD患者中显示出可靠的异常。我们的假设是，TBS诱导的TMS反应调制的改变是一种常见的神经病理生理特征，与ASD表型可靠地联系在一起，这不仅限于高功能成年人，而且在儿童和低功能个体中也是有效的。W因此预计，拟议研究的数据将满足ASD患者对快速、非侵入性、可靠和安全的内表型的重要需求，这些表型可用于不同年龄和功能水平的ASD患者。